Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis

Keith Hayes

doi:10.2147/ndt.s10469

journal article Open Access Apr 01, 2011

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis

Keith Hayes

Neuropsychiatric Disease and Treatment pp. 229 · Informa UK Limited

View at Publisher Save 10.2147/ndt.s10469

Topics

No keywords indexed for this article. Browse by subject →

Cited By

19

Exploring the Versatility of 4-Aminopyridine and Its Analogues in Managing Demyelinating Diseases (A Review)

R. Jino Affrald, Shoba Narayan · 2024

Russian Journal of Bioorganic Chemi...

Metrics

19

Citations

0

References

Details

Published: Apr 01, 2011
Pages: 229
License: View

Authors

K

Keith Hayes

Cite This Article

Keith Hayes (2011). Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatric Disease and Treatment, 229. https://doi.org/10.2147/ndt.s10469

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis

You May Also Like